Digest: Kamenskikh 2015 — Comparative Low-Intensity Device Therapies in Glaucoma
(Click to Expand)
Clinical takeaway: In 634 glaucomatous eyes, transcranial magnetic stimulation — either alone, combined with electrostimulation, or applied to cervical sympathetic ganglia — produced measurable gains in visual fields, stronger VEPs, and improved ocular blood flow.
Summary:
This trial compared three non-invasive regimens:
- Magnetotherapy alone
- Magnet + electrostimulation
- Magnet at cervical sympathetic ganglia
All groups improved, with Group 2 showing the strongest functional and electrophysiological gains, and Group 3 showing the most pronounced vascular improvements. Together, results confirm that magnet-based approaches can improve conduction and perfusion in POAG.
📂 Expand Data & Methods
Data & Methods
-
Design & Population: 397 patients (634 eyes) with POAG, stages I–III.
-
Interventions:
- Group 1: (182 eyes) Transcranial magnetotherapy
- Group 2: (258 eyes) Transcranial magnetotherapy + electrostimulation
- Group 3: (194 eyes) Magnetotherapy of cervical sympathetic ganglia
-
Protocol: 10 daily sessions, 20 min each.
-
Outcomes:
- Visual fields: Expansion with scotoma reduction in up to 65% of Group 2, ~30% of Group 3
- Electrophysiology: P100 amplitude ↑ 25–35%; latency ↓ 5–10 ms.
- Hemodynamics (PSCA):
- systolic velocity ↑ 15–30%;
- diastolic velocity ↑ up to ~80%;
- resistance index ↓ 15–35%.
-
Notes: Group 2 gave the strongest visual/functional gains, while Group 3 gave the greatest vascular improvements.
👉 If you want access to full abstracts, translations, or methodological notes, →📨 email us.
👉 To see how this research connects to real cases in practice, explore the Clinical Case Gallery